New view from the Hill

Science policy specialists watching for effects of change in control of Congress

| 3 min read

Register for free to listen to this article
Listen with Speechify
0:00
3:00
Share

When the lame duck session begins Tuesday, Congress will most likely pass a compromise version of the Homeland Security bill. But far less likely is quick action on the long-stalled budgets for the National Institutes of Health (NIH), the National Science Foundation (NSF), and most other science-related agencies, Hill staffers and observers say. Policy experts at the major US scientific and biomedical organizations will be watching this week's session closely, not only to monitor legislation produced now, but to glean insights into what may lie ahead for the next two years.

Measures of interest include: Appropriations bills to complete the doubling – and even begin the process of tripling – NIH's budget, as well as appropriations to begin doubling NSF's budget; passage of legislation creating the new Department of Homeland Security (DHS), which will direct the agenda of hundreds of millions of dollars in new bioterrorism-related research funds, possibly weakening ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to more than 35 years of archives, as well as TS Digest, digital editions of The Scientist, feature stories, and much more!
Already a member? Login Here

Meet the Author

  • Ted Agres

    This person does not yet have a bio.
Share
3D illustration of a gold lipid nanoparticle with pink nucleic acid inside of it. Purple and teal spikes stick out from the lipid bilayer representing polyethylene glycol.
February 2025, Issue 1

A Nanoparticle Delivery System for Gene Therapy

A reimagined lipid vehicle for nucleic acids could overcome the limitations of current vectors.

View this Issue
Enhancing Therapeutic Antibody Discovery with Cross-Platform Workflows

Enhancing Therapeutic Antibody Discovery with Cross-Platform Workflows

sartorius logo
Considerations for Cell-Based Assays in Immuno-Oncology Research

Considerations for Cell-Based Assays in Immuno-Oncology Research

Lonza
An illustration of animal and tree silhouettes.

From Water Bears to Grizzly Bears: Unusual Animal Models

Taconic Biosciences
Sex Differences in Neurological Research

Sex Differences in Neurological Research

bit.bio logo

Products

Tecan Logo

Tecan introduces Veya: bringing digital, scalable automation to labs worldwide

Explore a Concise Guide to Optimizing Viral Transduction

A Visual Guide to Lentiviral Gene Delivery

Takara Bio
Inventia Life Science

Inventia Life Science Launches RASTRUM™ Allegro to Revolutionize High-Throughput 3D Cell Culture for Drug Discovery and Disease Research

An illustration of differently shaped viruses.

Detecting Novel Viruses Using a Comprehensive Enrichment Panel

Twist Bio